Abelson Tyrosine Kinase Controls Phagosomal Acidification Required for Killing of Mycobacterium tuberculosis in Human Macrophages
- 15 October 2012
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 189 (8) , 4069-4078
Abstract
The mechanisms that regulate the acidification of intracellular compartments are key to host defense against pathogens. In this paper, we demonstrate that Abl tyrosine kinase, a master switch for cell growth and trafficking of intracellular organelles, controls the acidification of lysosomes in human macrophages. Pharmacological inhibition by imatinib and gene silencing of Abelson (Abl) tyrosine kinase reduced the lysosomal pH in human macrophages by increasing the transcription and expression of the proton pumping enzyme vacuolar-type H+-adenosine triphosphatase. Because lysosomal acidification is required for antimicrobial activity against intracellular bacteria, we determined the effect of imatinib on the growth of the major human pathogen Mycobacterium tuberculosis. Imatinib limited the multiplication of M. tuberculosis, and growth restriction was dependent on acidification of the mycobacterial compartment. The effects of imatinib were also active in vivo because circulating monocytes from imatinib-treated leukemia patients were more acidic than monocytes from control donors. Importantly, sera from imatinib-treated patients triggered acidification and growth restriction of M. tuberculosis in macrophages. In summary, our results identify the control of phagosomal acidification as a novel function of Abl tyrosine kinase and provide evidence that the regulation occurs on the level of the vacuolar-type H+-adenosine triphosphatase. Given the efficacy of imatinib in a mouse model of tuberculosis and our finding that orally administered imatinib increased the ability of human serum to trigger growth reduction of intracellular M. tuberculosis, clinical evaluation of imatinib as a complementary therapy of tuberculosis, in particular multidrug or extremely drug-resistant disease, is warranted.Keywords
This publication has 105 references indexed in Scilit:
- Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against TuberculosisCell Host & Microbe, 2011
- Vitamin D Is Required for IFN-γ–Mediated Antimicrobial Activity of Human MacrophagesScience Translational Medicine, 2011
- Acid Resistance inMycobacterium tuberculosisJournal of Bacteriology, 2009
- Anti-TNF immunotherapy reduces CD8+ T cell–mediated antimicrobial activity against Mycobacterium tuberculosis in humansJournal of Clinical Investigation, 2009
- Abl tyrosine kinases in T‐cell signalingImmunological Reviews, 2009
- Abl Kinases Regulate Autophagy by Promoting the Trafficking and Function of Lysosomal ComponentsJournal of Biological Chemistry, 2008
- Reactivation of chronic hepatitis B infection related to imatinib mesylate therapyHepatology International, 2008
- Development and dynamics of robust T-cell responses to CML under imatinib treatmentBlood, 2008
- RNAi Screen Reveals an Abl Kinase-Dependent Host Cell Pathway Involved in Pseudomonas aeruginosa InternalizationPLOS Pathogens, 2008
- M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid CellsCell, 2007